Psychotropic agents and uses thereof

MYPI2025004681A0Undetermined Publication Date: 2018-05-28LB PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025004681
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2017-05-18
Filing Date
2017-11-28
Publication Date
2018-05-28
Patent Text Reader

Abstract

Novel amisulpride derivatives and pharmaceutical compositions thereof are disclosed. The amisulpride derivative disclosed herein or a pharmaceutical composition thereof may have better membrane permeability compared to amisulpride. The amisulpride derivative disclosed herein or a pharmaceutical composition thereof may be used for antagonizing dopamine and / or serotonin (e.g., 5-HT2a) and / or α2 receptor in a subject, either individually or in combination with other CNS active agents. The amisulpride derivative disclosed herein or a pharmaceutical composition thereof may be used for treating one or more conditions responsive to modulation of dopamine and / or serotonin (e.g., 5-HT2a) and / or α2 receptor in a subject, either individually or in combination with other CNS active agents. The amisulpride derivative disclosed herein or a pharmaceutical composition thereof may be used for treating one or more disorders associated with an abnormality in levels of dopamine and / or serotonin in the brain, either individually or in combination with other CNS active agents. (No suitable figure)
Need to check novelty before this filing date? Find Prior Art